162 related articles for article (PubMed ID: 37769534)
1. Could immunoscore improve the prognostic and therapeutic management in patients with solid tumors?
Xu JL; Yang MX; Lan HR; Jin KT
Int Immunopharmacol; 2023 Nov; 124(Pt B):110981. PubMed ID: 37769534
[TBL] [Abstract][Full Text] [Related]
2. Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study.
Moretto R; Rossini D; Catteau A; Antoniotti C; Giordano M; Boccaccino A; Ugolini C; Proietti A; Conca V; Kassambara A; Pietrantonio F; Salvatore L; Lonardi S; Tamberi S; Tamburini E; Poma AM; Fieschi J; Fontanini G; Masi G; Galon J; Cremolini C
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37085190
[TBL] [Abstract][Full Text] [Related]
3. Light on life: immunoscore immune-checkpoint, a predictor of immunotherapy response.
Hijazi A; Antoniotti C; Cremolini C; Galon J
Oncoimmunology; 2023; 12(1):2243169. PubMed ID: 37554310
[TBL] [Abstract][Full Text] [Related]
4. Usefulness and robustness of Immunoscore for personalized management of cancer patients.
Marliot F; Pagès F; Galon J
Oncoimmunology; 2020 Oct; 9(1):1832324. PubMed ID: 33194318
[TBL] [Abstract][Full Text] [Related]
5. The consensus Immunoscore in phase 3 clinical trial (N0147) and impact on patient management decisions.
Lanzi A; Sinicrope FA; Benson AB; Galon J
Oncoimmunology; 2020 Jul; 9(1):1796003. PubMed ID: 32934890
[TBL] [Abstract][Full Text] [Related]
6. Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients.
Kirilovsky A; Marliot F; El Sissy C; Haicheur N; Galon J; Pagès F
Int Immunol; 2016 Aug; 28(8):373-82. PubMed ID: 27121213
[TBL] [Abstract][Full Text] [Related]
7. Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.
Galon J; Mlecnik B; Bindea G; Angell HK; Berger A; Lagorce C; Lugli A; Zlobec I; Hartmann A; Bifulco C; Nagtegaal ID; Palmqvist R; Masucci GV; Botti G; Tatangelo F; Delrio P; Maio M; Laghi L; Grizzi F; Asslaber M; D'Arrigo C; Vidal-Vanaclocha F; Zavadova E; Chouchane L; Ohashi PS; Hafezi-Bakhtiari S; Wouters BG; Roehrl M; Nguyen L; Kawakami Y; Hazama S; Okuno K; Ogino S; Gibbs P; Waring P; Sato N; Torigoe T; Itoh K; Patel PS; Shukla SN; Wang Y; Kopetz S; Sinicrope FA; Scripcariu V; Ascierto PA; Marincola FM; Fox BA; Pagès F
J Pathol; 2014 Jan; 232(2):199-209. PubMed ID: 24122236
[TBL] [Abstract][Full Text] [Related]
8. Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma.
Maibach F; Sadozai H; Seyed Jafari SM; Hunger RE; Schenk M
Front Immunol; 2020; 11():2105. PubMed ID: 33013886
[TBL] [Abstract][Full Text] [Related]
9. Construction and Validation of a Tumor Microenvironment-Based Scoring System to Evaluate Prognosis and Response to Immune Checkpoint Inhibitor Therapy in Lung Adenocarcinoma Patients.
Huang P; Xu L; Jin M; Li L; Ke Y; Zhang M; Zhang K; Lu K; Huang G
Genes (Basel); 2022 May; 13(6):. PubMed ID: 35741714
[TBL] [Abstract][Full Text] [Related]
10. The consensus Immunoscore in phase 3 clinical trials; potential impact on patient management decisions.
Pagès F; Taieb J; Laurent-Puig P; Galon J
Oncoimmunology; 2020 Aug; 9(1):1812221. PubMed ID: 32939329
[TBL] [Abstract][Full Text] [Related]
11. Immunoscore immune checkpoint using spatial quantitative analysis of CD8 and PD-L1 markers is predictive of the efficacy of anti- PD1/PD-L1 immunotherapy in non-small cell lung cancer.
Ghiringhelli F; Bibeau F; Greillier L; Fumet JD; Ilie A; Monville F; Laugé C; Catteau A; Boquet I; Majdi A; Morgand E; Oulkhouir Y; Brandone N; Adam J; Sbarrato T; Kassambara A; Fieschi J; Garcia S; Lepage AL; Tomasini P; Galon J
EBioMedicine; 2023 Jun; 92():104633. PubMed ID: 37244159
[TBL] [Abstract][Full Text] [Related]
12. [Advances in predictive biomarkers associated with immune checkpoint inhibitors for tumor therapy].
Guo R; Li X; Hao M; Liang Y; Wang L; Yang Z
Sheng Wu Gong Cheng Xue Bao; 2023 Apr; 39(4):1403-1424. PubMed ID: 37154314
[TBL] [Abstract][Full Text] [Related]
13. World-Wide Immunoscore Task Force: meeting report from the "Melanoma Bridge", Napoli, November 30th-December 3rd, 2016.
Galon J; Lugli A; Bifulco C; Pages F; Masucci G; Marincola FM; Ascierto PA
J Transl Med; 2017 Oct; 15(1):212. PubMed ID: 29058595
[TBL] [Abstract][Full Text] [Related]
14. Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation.
Paver EC; Cooper WA; Colebatch AJ; Ferguson PM; Hill SK; Lum T; Shin JS; O'Toole S; Anderson L; Scolyer RA; Gupta R
Pathology; 2021 Feb; 53(2):141-156. PubMed ID: 33388161
[TBL] [Abstract][Full Text] [Related]
15. [Intratumoral immune microenvironment and survival: the immunoscore].
Galon J; Bindea G; Mlecnik B; Angell H; Lagorce C; Todosi AM; Berger A; Pagès F
Med Sci (Paris); 2014 Apr; 30(4):439-44. PubMed ID: 24801041
[TBL] [Abstract][Full Text] [Related]
16. Immune checkpoint inhibitors in luminal gastrointestinal malignancies: going beyond MSI-H/dMMR, TMB and PD-L1.
Lefler DS; Snook AE; Bashir B
Immunotherapy; 2022 Aug; 14(11):885-902. PubMed ID: 35694998
[TBL] [Abstract][Full Text] [Related]
17. Immunoscore and its introduction in clinical practice.
Galon J; Lanzi A
Q J Nucl Med Mol Imaging; 2020 Jun; 64(2):152-161. PubMed ID: 32107902
[TBL] [Abstract][Full Text] [Related]
18. A novel prognostic immunoscore based on The Cancer Genome Atlas to predict overall survival in colorectal cancer patients.
Tang Z; Wu Y; Sun D; Xue X; Qin L
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34608935
[TBL] [Abstract][Full Text] [Related]
19. From the Immune Profile to the Immunoscore: Signatures for Improving Postsurgical Prognostic Prediction of Pancreatic Neuroendocrine Tumors.
Wei M; Xu J; Hua J; Meng Q; Liang C; Liu J; Zhang B; Wang W; Yu X; Shi S
Front Immunol; 2021; 12():654660. PubMed ID: 33968055
[TBL] [Abstract][Full Text] [Related]
20. Cancer classification using the Immunoscore: a worldwide task force.
Galon J; Pagès F; Marincola FM; Angell HK; Thurin M; Lugli A; Zlobec I; Berger A; Bifulco C; Botti G; Tatangelo F; Britten CM; Kreiter S; Chouchane L; Delrio P; Arndt H; Asslaber M; Maio M; Masucci GV; Mihm M; Vidal-Vanaclocha F; Allison JP; Gnjatic S; Hakansson L; Huber C; Singh-Jasuja H; Ottensmeier C; Zwierzina H; Laghi L; Grizzi F; Ohashi PS; Shaw PA; Clarke BA; Wouters BG; Kawakami Y; Hazama S; Okuno K; Wang E; O'Donnell-Tormey J; Lagorce C; Pawelec G; Nishimura MI; Hawkins R; Lapointe R; Lundqvist A; Khleif SN; Ogino S; Gibbs P; Waring P; Sato N; Torigoe T; Itoh K; Patel PS; Shukla SN; Palmqvist R; Nagtegaal ID; Wang Y; D'Arrigo C; Kopetz S; Sinicrope FA; Trinchieri G; Gajewski TF; Ascierto PA; Fox BA
J Transl Med; 2012 Oct; 10():205. PubMed ID: 23034130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
